BlackRock, Inc. Adds To Parnell Pharmaceuticals Holdings BlackRock, Inc. just filed a 13G "Statement of acquisition of beneficial ownership". BlackRock, Inc. now owns 878,722 shares of Parnell Pharmaceuticals. This represents 6.6% of Parnell Pharmaceuticals. http://www.sec.gov/Archives/edgar/data/1603429/000021545715000465/0000215457-15-000465-index.htm .